Omalizumab: Anti-IgE therapy in allergy.
Omalizumab is a humanized, monoclonal anti-IgE antibody that binds specifically to circulating IgE molecules, thus interrupting the allergic cascade. Omalizumab has been shown to be highly effective in treating children and adults with moderate to severe allergic asthma. Beyond this indication, the mode of action itself suggests that omalizumab is not only an antiasthmatic drug but also a promising therapeutic option for various allergic conditions, including allergic rhinitis, food allergy, urticaria, allergic bronchopulmonary aspergillosis, insect hypersensitivity, and atopic dermatitis. However, data from double-blind, placebo-controlled clinical trials are only available for allergic rhinitis and moderate to severe bronchial asthma. The aim of this review is to discuss the current clinical data as well as possible further indications of omalizumab treatment.
Schwerpunkt Pädiatrische Pneumologie, Klinik für Kinder-und Jugendmedizin, University Luebeck, Ratzeburger Allee 160, 23538, Luebeck, Germany. kopp@paedia.ukl.mu-luebeck.de
Matthias Volkmar
MV
Kopp
D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy*; D007073:Immunoglobulin E; D000069444:Omalizumab; D016032:Randomized Controlled Trials as Topic
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000069444:Omalizumab; D007073:Immunoglobulin E
J Am Acad Dermatol. 2006 Jul;55(1):168-70
16781320
Clin Exp Allergy. 2004 Apr;34(4):632-8
15080818
Am J Respir Crit Care Med. 2004 Sep 15;170(6):583-93
15172898
Pediatr Pulmonol. 2008 Jun;43(6):607-10
18433040
Clin Exp Allergy. 1998 Jun;28(6):664-7
9677128
J Allergy Clin Immunol. 2002 Nov;110(5):728-35
12417881
Int Arch Allergy Immunol. 2010;153(3):288-93
20484928
Allergy. 2010 Jan;65(1):134-5
19804448
J Allergy Clin Immunol. 2006 Jan;117(1):134-40
16387596
J Allergy Clin Immunol. 2003 Feb;111(2):278-84
12589345
J Allergy Clin Immunol. 2010 Sep;126(3):665-6
20673981
J Immunol. 1997 Feb 1;158(3):1438-45
9013989
Int Arch Allergy Immunol. 2011;154(2):177-80
20733327
J Am Acad Dermatol. 2005 Aug;53(2):338-40
16021135
J Immunol. 2005 Oct 1;175(7):4167-73
16177053
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003559
16625585
J Allergy Clin Immunol. 2002 Feb;109(2):274-80
11842297
Allergy. 2010 Jul;65(7):931-2
19930230
Pediatr Allergy Immunol. 2010 Feb;21(1 Pt 2):e160-5
19732370
J Allergy Clin Immunol. 2010 Feb;125(2):490-1
20159260
Ann Allergy Asthma Immunol. 2010 Jan;104(1):95-7
20143654
J Allergy Clin Immunol. 2007 Nov;120(5):1223-5
17936892
Ann Dermatol. 2010 Aug;22(3):349-52
20711278
Thorax. 2007 Mar;62(3):276-7
17329558
J Allergy Clin Immunol. 2001 Aug;108(2):184-90
11496232
Allergy. 2005 Mar;60(3):309-16
15679715
Pediatr Pulmonol. 2009 May;44(5):516
19382216
JAMA. 2001 Dec 19;286(23):2956-67
11743836
Allergol Int. 2006 Dec;55(4):379-86
17130680
Clin Exp Allergy. 2009 Feb;39(2):271-9
19016798
Pediatr Pulmonol. 2008 Dec;43(12):1249-51
19009619
Pediatr Allergy Immunol. 2007 Sep;18(6):523-7
17680911
J Allergy Clin Immunol. 2004 Feb;113(2):297-302
14767445
Eur Respir J. 2001 Aug;18(2):254-61
11529281
Pediatrics. 2001 Aug;108(2):E36
11483846
J Allergy Clin Immunol. 2009 Dec;124(6):1210-6
19910033
J Allergy Clin Immunol. 2003 Jan;111(1):87-90
12532101
Monaldi Arch Chest Dis. 2008 Jun;69(2):78-80
18837422
Curr Med Res Opin. 2006 Nov;22(11):2201-8
17076981
J Allergy Clin Immunol. 2005 Mar;115(3):459-65
15753888
Allergy. 2004 Jul;59(7):709-17
15180757
Acta Derm Venereol. 2010 Jul;90(4):443-4
20574627
Ann Allergy Asthma Immunol. 2003 Aug;91(2):160-7
12952110